Stephen R. Durham
Stephen R Durham is Head of Section for Allergy and Clinical Immunology at NHLI, Imperial College and Professor of Allergy and Respiratory Medicine at Royal Brompton Hospital London. Professor Durham qualified from Downing College Cambridge and Guy's Hospital London in 1976. He trained in general and respiratory medicine at Addenbrookes Hospital Cambridge, Royal Brompton Hospital and John Radcliffe/Churchill Hospitals in Oxford, returning to NHLI as Senior lecturer in 1988. Before taking up his present position in 2004, he was Reader in Upper Respiratory Medicine.
He has studied basic mechanisms of allergic rhinitis and asthma and the influence of treatment. He is a principal investigator for a number of international trials that have resulted in Europe-wide registration of an Alum-based grass pollen vaccine for injection and a sublingual grass allergen tablet, the first allergy vaccine to be registered in the UK for 35 years. Professor Durham is the current President of the British Society for Allergy and Clinical Immunology and a member of the Immune Tolerance Network Steering Committee of the National Institutes of health. He is former Chair of the Research Committee of the World Allergy Organisation and council member of Collegium Internationale Allergologicum.